News Release
Brian Capell
Brian Capell, MD

Brian Capell, MD, an assistant professor of Dermatology, received a $100,000 grant from the Prevent Cancer Foundation. The award will build on Capell’s previous research showing that modulating the types of fatty acids in the diet may prevent the formation of skin and oral squamous cell carcinomas. Squamous cell carcinoma, which can occur in various places throughout the body, is the most common form of cancer worldwide.






Virginia M.-Y. Lee
Virginia M.-Y. Lee, PhD

Virginia M.-Y. Lee, PhD, the John H. Ware 3rd Professor in Alzheimer’s Research, has been awarded the 2024 Outstanding Innovation in Neurodegenerative Disease Research Prize from The Rainwater Charitable Foundation, one of the largest independent funders of neurodegenerative research, in honor of her career spanning multiple decades of discoveries that helped shape awareness and understanding of tau, a protein whose dysregulation is involved in multiple neurodegenerative disorders, including Alzheimer’s disease, Amyotrophic Lateral Sclerosis (ALS), and Progressive Supranuclear Palsy. The $400,000 prize will be presented during the Tau2024 Global Conference in March.




Aaron Richterman, MD, MPH, an assistant professor of Infectious Diseases, and Harsha Thirumurthy, PhD, a professor of Medical Ethics & Health Policy, have been recognized by the Clinical Research (CR) Forum, receiving one of the Top 10 Clinical Research Achievement Awards from 2024, which honor groundbreaking achievements in clinical research from across the nation. The pair were honored for their work studying the effects of cash transfer programs on HIV-related outcomes in 42 countries from 1996 to 2019, which was published in Nature Human Behavior. The award recipients are selected by a CR Forum panel from clinical research studies published in peer-reviewed journals in 2023. They are based on the degree of innovation and novelty involved in the advancement of science; contribution to the understanding of human disease and/or physiology; and potential impact upon the diagnosis, prevention, and/or treatment of disease.


Marco Ruella
Marco Ruella, MD

Marco Ruella, MD, an assistant professor of Hematology-Oncology, has been awarded a Lupus Mechanisms and Targets Award of $600,000 from the Lupus Research Alliance for research to investigate molecular pathways or targets that will lead to new or improved therapies for individuals with systemic lupus erythematosus. His project will focus on using CAR-T cells to precisely target disease-causing B cells.






Andrea L.C. Schneider
Andrea L.C. Schneider, MD, PhD

Andrea L.C. Schneider, MD, PhD, an assistant professor of Neurology and Epidemiology, has been recognized by the National Institutes of Health for the Early Stage Investigator Lecture. The Lecture recognizes early career prevention scientists who have already made outstanding research contributions to their respective fields and are poised to become future leaders in prevention research. Schneider’s research investigates the prevalence of traumatic brain injury (TBI), conditions associated with it, and how to prevent the long term after effects of TBI, like mortality, neurodegeneration, and dementia.

Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.

The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.

The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.

Share This Page: